IL1B and atherosclerosis: This information will help delineate the pathogenesis of atherosclerosis, and will help uncover other, currently unknown, mechanisms involving IL-1β, in order to develop anti-IL-1β therapeutics for reducing the incidence of cardiovascular events 20.